Compugen Ltd (Israel) Profile

Risk Adjusted Return

From 0 to 100

   

Chance of Distress     

From 0 to 100%

Equity ratings for Compugen Ltd are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting February 24, 2019 and ending today April 25, 2019. Click here to learn more.

Compugen Ltd Income Statement Over Time

Net Income    Revenues    

Compugen Ltd Key Fundamentals

Compugen Ltd Against Markets

Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 89 people. more
NameCompugen Ltd
President CEO, DirectorAnat CohenDayagView All
Macroaxis Advice
InstrumentIsrael Stock View All
RegionMiddle East
Business AddressAzrieli Center
Foreign Associate  USA
ExchangeTel Aviv Stock Exchange
CIK Number0001119774
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.cgen.com
Phone972 3 765 8585
CurrencyILS - Israeli Shekel
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterDecember 31, 2018
Last Fiscal Year EndDecember 31, 2018

Compugen LtdCorporate Directors

Joshua Shemer Independent External Director
Michal Preminger Director
Dov Hershberg Director
Check also Trending Equities. Please also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Search macroaxis.com